AKT1 and melanoma: Mechanistically, SOX10 activates both MAPK and PI3K/AKT pathways, which are pivotal for melanoma cell survival and proliferation,108, 109 while also influencing invasive capacity, as evidenced by reduced cell invasion following SOX10 inhibition.110